Market Tracker

02/27 5:16pm ET

Edwards Lifesciences Corp (NYSE:EW)

94.66
Delayed Data
As of Feb 27
 -0.10 / -0.11%
Today’s Change
81.12
Today|||52-Week Range
121.75
+1.02%
Year-to-Date
Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease
Feb 22 / MotleyFool.com - Paid Partner Content
Are Edwards Lifesciences Best Days Behind It?
Feb 21 / MotleyFool.com - Paid Partner Content
Baron Opportunity Fund Comments on Edwards
Feb 21 / GuruFocus News - Paid Partner Content
Why Edwards Lifesciences Could Bounce Back
Feb 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close94.76
Today’s open94.68
Day’s range93.78 - 95.29
Volume1,450,661
Average volume (3 months)2,601,114
Market cap$20.1B
Dividend yield--
Data as of 4:01pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)+16.00%
Earnings growth (this year)+17.58%
Earnings growth (next 5 years)+15.90%
Revenue growth (last year)+18.85%
P/E ratio36.3
Price/Sales6.89
Price/Book7.66

Competitors

 Today’s
change
Today’s
% change
SNNSmith & Nephew PLC-0.32-1.04%
ISRGIntuitive Surgical-2.83-0.38%
STESTERIS plc+0.10+0.14%
HRCHill-Rom Holdings In...+0.22+0.33%
Data as of 4:02pm ET, 02/27/2017

Financials

Next reporting dateApril 25, 2017
EPS forecast (this quarter)$0.82
Annual revenue (last year)$3.0B
Annual profit (last year)$569.5M
Net profit margin19.22%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts